Hallmarks of cardiovascular ageing

M Abdellatif, PP Rainer, S Sedej… - Nature Reviews …, 2023 - nature.com
Normal circulatory function is a key determinant of disease-free life expectancy (healthspan).
Indeed, pathologies affecting the cardiovascular system, which are growing in prevalence …

Pathophysiology of hypertension: the mosaic theory and beyond

DG Harrison, TM Coffman, CS Wilcox - Circulation research, 2021 - Am Heart Assoc
Dr Irvine Page proposed the Mosaic Theory of Hypertension in the 1940s advocating that
hypertension is the result of many factors that interact to raise blood pressure and cause end …

Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

G Filippatos, SD Anker, R Agarwal, B Pitt, LM Ruilope… - Circulation, 2021 - Am Heart Assoc
Background: The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease
Progression in Diabetic Kidney Disease) evaluated the effect of the nonsteroidal, selective …

Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology

SJ Forrester, GW Booz, CD Sigmund… - Physiological …, 2018 - journals.physiology.org
The renin-angiotensin-aldosterone system plays crucial roles in cardiovascular physiology
and pathophysiology. However, many of the signaling mechanisms have been unclear. The …

Insights into salt handling and blood pressure

DH Ellison, P Welling - New England Journal of Medicine, 2021 - Mass Medical Soc
Salt Handling and Blood Pressure Salt intake is associated with blood pressure, but the
relationship is complex. This review highlights the interplay among renal salt transport, salt …

Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease

P Lacolley, V Regnault, P Segers… - Physiological …, 2017 - journals.physiology.org
The cushioning function of large arteries encompasses distension during systole and recoil
during diastole which transforms pulsatile flow into a steady flow in the microcirculation …

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

GL Hundemer, GC Curhan, N Yozamp… - The lancet Diabetes & …, 2018 - thelancet.com
Background Mineralocorticoid receptor (MR) antagonists are the recommended medical
therapy for primary aldosteronism. Whether this recommendation effectively reduces …

Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease

U Kintscher, GL Bakris, P Kolkhof - British Journal of …, 2022 - Wiley Online Library
Mineralocorticoid receptor antagonists (MRAs) are key agents in guideline‐oriented drug
therapy for cardiovascular diseases such as chronic heart failure with reduced ejection …

[HTML][HTML] Oxidative stress: a unifying paradigm in hypertension

RM Touyz, FJ Rios, R Alves-Lopes, KB Neves… - Canadian journal of …, 2020 - Elsevier
The etiology of hypertension involves complex interactions among genetic, environmental,
and pathophysiologic factors that influence many regulatory systems. Hypertension is …

Aldosterone as a mediator of cardiovascular damage

F Buffolo, M Tetti, P Mulatero, S Monticone - Hypertension, 2022 - Am Heart Assoc
Besides the physiological regulation of water, sodium, and potassium homeostasis,
aldosterone modulates several physiological and pathological processes in the …